Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
After Re-Engineering Itself, Verdezyne Sets Course to Develop Biofuels and “Green” Industrial Chemicals
|
Bruce V. Bigelow |
11/20/09 |
San Diego
|
|
ISB Nabs $8M for Cancer Genome
|
Luke Timmerman |
11/10/09 |
Seattle
|
|
Life Technologies Acquiring BioTrove
|
Bruce V. Bigelow |
11/10/09 |
San Diego
|
|
Helicos Takes Itself Off Block
|
Luke Timmerman |
11/09/09 |
Boston
|
|
Ion Torrent, Stealthy Company Tied to Harvard’s George Church, Nabs $23M Venture Deal
|
Luke Timmerman |
11/06/09 |
Boston
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
ISB Cuts Deal to Sequence 100 Genomes
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles
|
Luke Timmerman |
10/06/09 |
Seattle
|
|
UW Gets $25M For Genome Center
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
Helicos Biosciences, Running Low on Cash, Snaps Up $10M Lifeline
|
Luke Timmerman |
09/16/09 |
Boston
|
|
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug
|
Luke Timmerman |
09/10/09 |
San Diego
|
|
OVP Company Does 14 Genomes
|
Luke Timmerman |
09/09/09 |
Seattle
|
|
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/03/09 |
Seattle
|
|
The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle
|
Luke Timmerman |
09/02/09 |
Seattle
|
|
Can The Genome Be Cracked for $5,000? OVP, Enterprise Partners Say Yes in $45M Round
|
Luke Timmerman |
08/24/09 |
National
|
|
Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial
|
Luke Timmerman |
08/10/09 |
National
|
|
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
Inside the Microsoft-Yahoo Deal, Covance Buys Merck’s Rosetta Lab, Delve Teams Up with Akamai, & More Seattle-Area Deals News
|
Gregory T. Huang |
08/04/09 |
Seattle
|
|
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/28/09 |
Seattle
|
|
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use
|
Luke Timmerman |
05/27/09 |
Seattle
|
|
X Prize Founder Peter Diamandis Targets Breakthroughs With More Incentive Prizes
|
Bruce V. Bigelow |
05/22/09 |
San Diego
|
|
The $1,000 Genome is Coming: How Will It Change the World?
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Knome Offers Thriftier Gene Sequencing
|
Roxanne Palmer |
05/18/09 |
Boston
|
|
Google, Microsoft May Help Usher in Personalized Medicine Wave, Says George Church
|
Luke Timmerman |
05/12/09 |
Boston
|
|
Novocell Hires John West as CEO
|
Luke Timmerman |
05/11/09 |
San Diego
|
|
RainDance Reports $6M Financing
|
Ryan McBride |
05/07/09 |
Boston
|
|
Illumina Sues Affymetrix for Patent Infringement of Genetic Analysis Technology
|
Juha-Pekka Tikka |
05/05/09 |
San Diego
|
|
Urbanspoon Exits, Likewise Lands $10M, Zymo Licenses Drugs to Startup, & More Seattle-Area Deals News
|
Gregory T. Huang |
05/05/09 |
Seattle
|
|
Illumina Anticipates Purchasing Slowdown
|
Juha-Pekka Tikka |
04/22/09 |
San Diego
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
